Although the median survival was numerically different (77 and 120 months, respectively for PD-L1 expression in tumor> 1% and ≤ 1%; p = 0.224) for patients whose tumors had high PD-L1 expression, this was not statistically significant (Figure S10). Here, CD274 is linked to neoplasm.